Paper14660
Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
Marlin GE and 2 others. Br J Clin Pharmacol, 1977. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols. Papers, record 14660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14660
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Albuterol | Major topic |
| Catechols | Major topic |
| Piperidines | Major topic |
| Receptors, Adrenergic | Major topic |
| Receptors, Adrenergic, beta | Major topic |
| Adult | |
| Aerosols | |
| Aged | |
| Airway Obstruction | |
| Bronchodilator Agents | |
| Forced Expiratory Volume | |
| Heart Rate | |
| Humans | |
| Middle Aged | |
| Placebos |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,940 | Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man. | Br J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/10940 | PubMed |
| 2 | 1,116,382 | Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol. | Curr Med Res Opin | 1975 | https://conductscience.org/library/papers/1116382 | PubMed |
| 3 | 1,139,193 | Intravenous treatment with rimiterol and salbutamol in asthma. | Br Med J | 1975 | https://conductscience.org/library/papers/1139193 | PubMed |
| 4 | 240,780 | The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients. | Int J Clin Pharmacol Biopharm | 1975 | https://conductscience.org/library/papers/240780 | PubMed |
| 5 | 4,147,213 | Clinical assessment of bronchodilator drugs delivered by aerosol. | Thorax | 1973 | https://conductscience.org/library/papers/4147213 | PubMed |
| 6 | 4,401,704 | A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man. | J Clin Pharmacol New Drugs | 1972 | https://conductscience.org/library/papers/4401704 | PubMed |
| 7 | 4,402,115 | Comparison of the bronchodilatory action of two drugs. | Int Z Klin Pharmakol Ther Toxikol | 1971 | https://conductscience.org/library/papers/4402115 | PubMed |
| 8 | 4,404,808 | The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease. | Scand J Respir Dis | 1972 | https://conductscience.org/library/papers/4404808 | PubMed |
| 9 | 4,932,744 | Preliminary studies of a new bronchodilator (WG 253) in man. | J Clin Pharmacol New Drugs | 1971 | https://conductscience.org/library/papers/4932744 | PubMed |
| 10 | 5,411,446 | Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. | Br Med J | 1970 | https://conductscience.org/library/papers/5411446 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,117,302 | Effect of intravenous injection of rimiterol in asthma. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6117302 | PubMed |
| 533,582 | Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/533582 | PubMed |
| 19,226 | Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma. | Drugs | 1977 | https://conductscience.org/library/papers/19226 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADRB2 | 154 | PubTator's text mining | https://conductscience.org/library/genes/154 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14660
GET https://conductscience.org/api/papers/v1/14660/authors